An innovative external brace to ensure patency and maturity of arteriovenous fistulas in haemodialysis patients.

Project Information

VasQ

Grant agreement ID: 710564

DOI

10.3030/710564

Project closed

EC signature date 25 November 2015

Start date 1 December 2015

End date 31 March 2016

Funded under

• SOCIETAL CHALLENGES - Health, demographic change and well-being

Total cost

€ 71 429,00

EU contribution

€ 50 000,00

Coordinated by

LAMINATE MEDICAL TECHNOLOGIES LTD
Israel

Periodic Reporting for period 1 - VasQ (An innovative external brace to ensure patency and maturity of arteriovenous fistulas in haemodialysis patients.)

Reporting period: 2015-12-01 to 2016-03-31

Summary of the context and overall objectives of the project

During the Phase 1 feasibility study Laminate undertook a deep study of the technical aspects of its VasQ device including industrialisation and benefits. Business elements examined included deep market analysis and an in-depth customer/end-user study. The activities contributed to the development of a plan to bring the medical device to market and the decision to apply for Phase 2 funding through the SME Instrument.

Work performed from the beginning of the project to the end of the period covered by the report and main results achieved so far

Partners were investigated and engaged for carrying out production of the device. The type of clinical trial required to commercialise the device was identified and elaborated. Users were contacted and accounted for in the report. A clinical synopsis for the trial was prepared. The value chain was filled out by the addition of the partners to the consortium.

Progress beyond the state of the art and expected potential impact (including the socio-economic impact and the wider societal implications of the project so far)

The only medical device in its field which improves the maturation/usability rate of arteriovenous fistulas over time.

The device.